Newfeed

Grant to support IND-enabling toxicology and Phase 1/1b development of novel cardiac-safe ibogaine analog, GM-3009 NEW YORK, March 14, 2024 /PRNewswire/ — Gilgamesh Pharmaceuticals, a clinical-stage neuroscience company committed to developing best-in-class, rapid-acting treatments for mental

DUBLIN, March 14, 2024 /PRNewswire/ — The “Global Mobility and the Employment of Overseas Nationals Training Course” has been added to  ResearchAndMarkets.com’s offering. The law and best practice around global mobility and the employment of overseas nationals is a fast-mov

Magazine made for you.

Featured:

No posts were found for provided query parameters.

Elsewhere: